Fetal Alcohol Syndrome – Symptoms and Treatment Methods. Alcohol Consumption During Pregnancy

Ethyl alcohol, the intoxicating compound present in fermented and distilled beverages—including beer, wine, vodka, whisky, and liqueurs—constitutes a potent neurotoxin with particularly severe implications for pregnant women. Owing to inherent physiological distinctions such as reduced total body water content and divergent metabolic pathways, females exhibit heightened susceptibility to alcohol’s deleterious effects compared to males. Furthermore, the enzymatic activity of hepatic and gastric systems responsible for ethanol catabolism differs significantly in women. Critically, the placental barrier offers no protection against alcohol, which freely traverses into the fetal circulation, attaining equivalent blood concentrations to those of the mother within 40–60 minutes. Given the immaturity of fetal organs—particularly the liver—and an enzymatic capacity approximately 50% lower than that of adults, alcohol persists longer in the fetal system, exacerbating its cytotoxic impact. The consequences of prenatal alcohol exposure are permanent and encompass a spectrum of disorders, most notably fetal alcohol syndrome (FAS), the milder fetal alcohol effects (FAE), and a range of neurocognitive developmental impairments. Since no empirically validated "safe threshold" of alcohol consumption during pregnancy exists, complete abstinence throughout gestation is strongly advised to preclude irreversible harm to the developing child.

Fetal Alcohol Spectrum Disorder (FAS) constitutes a multifaceted array of neurocognitive and physiological impairments arising from prenatal exposure to ethanol, a teratogenic agent with well-documented deleterious effects on embryonic and fetal development. The primary and empirically validated causative factor is the maternal ingestion of ethanol-containing beverages during gestation, wherein ethanol—recognized for its teratogenic properties—disrupts critical stages of organogenesis and neural differentiation. The pathophysiological pathways through which alcohol precipitates psychosomatic dysfunction in the fetus include ethanol-induced vasoconstriction of uteroplacental vessels, resulting in chronic fetal hypoxia due to compromised oxygen transfer across the placental barrier. Furthermore, ethanol inhibits the synthesis of essential structural proteins and enzymatic compounds, delays cellular proliferation, and impairs tissue differentiation—consequences of disrupted nutrient delivery via the placenta. Additionally, ethanol metabolism generates excessive reactive oxygen species, whose accumulation inflicts mitochondrial damage within fetal cells, thereby predisposing the individual to metabolic disorders in later life. In severe instances, ethanol toxicity may trigger premature uterine contractions, lead to spontaneous abortion, preterm delivery, or—under the most critical circumstances—result in fetal or maternal mortality due to acute multi-organ failure.

Fetal alcohol spectrum disorder (FAS) presents with highly distinctive and identifiable symptoms that can be methodically categorized into two primary domains: **structural anatomical abnormalities** and **psychocognitive developmental impairments** in the affected child. The first category encompasses morphological deviations observable from infancy, including **microcephaly** (an abnormally small cranial circumference), **midfacial hypoplasia** (flattened facial features with a characteristic profile), and **facial dysmorphia** — such as widely spaced, small eyes (*hypertelorism*), a thin and poorly defined upper lip, excessive skin folds at the medial canthus (*epicanthal folds*), a flattened **philtrum**, a shortened nasal bridge, mandibular hypoplasia (*micrognathia*), and **malformed auricles**. Additionally, children with FAS frequently exhibit **low birth weight**, **bone mineralization disorders**, **congenital cardiac and renal defects**, and **sensory organ dysfunctions** affecting both hearing and vision. The second category pertains to **neurocognitive deficits**, including **diminished intelligence quotient (IQ)**, **psychomotor hyperactivity**, **persistent attention and concentration deficits**, **difficulties with abstract reasoning**, **impaired causal-logical inference**, and **challenges in establishing enduring interpersonal relationships**. Behavioral manifestations also include **emotional immaturity**, **outbursts of anger or aggression**, and, in later developmental stages, **depressive tendencies** alongside **social maladaptation difficulties**.

FAS is an incurable disease. A child with FAS can be helped in part by giving him or her choline during the fetal period, which is an element of the phospholipids that build up m... other nerve cells (including the brain). However, the best antidote to FAS may be to prevent the development of further, typical FAS disorders in a child. Changes in the brain that have occurred are irreversible.